Showing content from https://pubmed.ncbi.nlm.nih.gov/29908051/ below:
Use of Colorectal Cancer Screening Tests by State
doi: 10.5888/pcd15.170535. Use of Colorectal Cancer Screening Tests by State
Affiliations
Affiliations
- 1 Centers for Disease Control and Prevention, Division of Cancer Control and Prevention, 4770 Buford Hwy, MS F76, Atlanta, GA 30341. Email: dajoseph@cdc.gov.
- 2 Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia.
Item in Clipboard
Use of Colorectal Cancer Screening Tests by State
Djenaba A Joseph et al. Prev Chronic Dis. 2018.
doi: 10.5888/pcd15.170535. Affiliations
- 1 Centers for Disease Control and Prevention, Division of Cancer Control and Prevention, 4770 Buford Hwy, MS F76, Atlanta, GA 30341. Email: dajoseph@cdc.gov.
- 2 Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia.
Item in Clipboard
No abstract available
PubMed Disclaimer
Figures
Figure
Progress toward increased use of colorectal…
Figure
Progress toward increased use of colorectal cancer (CRC) screening tests, by state. A. Percentage…
Figure
Progress toward increased use of colorectal cancer (CRC) screening tests, by state. A. Percentage of respondents aged 50 to 75 who reported being up to date with CRC screening in the 2016 Behavioral Risk Factor Surveillance System (1). The percentage up to date for the United States overall was 67.3%. B. The absolute change in percentage of respondents aged 50 to 75 who reported being up to date with CRC screening from 2012 through 2016, by state, Behavioral Risk Factor Surveillance System, 2012 (2), 2016 (1). Up to date is defined as having had a fecal occult blood test (FOBT) within the past year, sigmoidoscopy within the past 5 years with FOBT within the past 3 years, or colonoscopy within the past 10 years. Source: CDC Behavioral Risk Factor Surveillance System (BRFSS), BRFSS, 2012 and 2016 (–2). [Table: see text]
Cited by
- Identification of taxonomic changes in the fecal bacteriome associated with colorectal polyps and cancer: potential biomarkers for early diagnosis.
Grion BAR, Fonseca PLC, Kato RB, García GJY, Vaz ABM, Jiménez BN, Dambolenea AL, Garcia-Etxebarria K, Brenig B, Azevedo V, Bujanda L, Banales JM, Góes-Neto A. Grion BAR, et al. Front Microbiol. 2024 Jan 11;14:1292490. doi: 10.3389/fmicb.2023.1292490. eCollection 2023. Front Microbiol. 2024. PMID: 38293554 Free PMC article.
References
-
- Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System. Atlanta, Georgia: US Department of Health and Human Services, Centers for Disease Control and Prevention, 2016. https://www.cdc.gov/brfss/annual_data/annual_2016.html. Accessed September 1, 2017.
-
- Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System Survey Data. Atlanta, Georgia: US Department of Health and Human Services, Centers for Disease Control and Prevention, 2012. https://www.cdc.gov/brfss/annual_data/annual_2012.html. Accessed September 1, 2017.
-
- Centers for Disease Control and Prevention. National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER Stat Database: NPCR and SEER Incidence — USCS 2001–2014 Public Use Research Database, Released August 2017, based on the November 2016 submission. www.cdc.gov/cancer/npcr/public-use. Accessed September 15, 2017.
-
- US Preventive Services Task Force. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med 2008;149(9):627–37. 10.7326/0003-4819-149-9-200811040-00243 - DOI - PubMed
-
- Centers for Disease Control and Prevention. Vital signs: colorectal cancer screening test use — United States, 2012. MMWR Morb Mortal Wkly Rep 2013;62(44):881–8. - PMC - PubMed
RetroSearch is an open source project built by @garambo
| Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3